With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

Real-world data showed that low-risk patients who underwent transcatheter aortic valve replacement (TAVR) had 1-year ...

JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.

TAVR has seen substantial growth over the past ... The guidelines discourage the use of older techniques like transapical or ...

With regional differences in which name is used for the aortic fix, some say unity is needed. Others can live with both.

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the ...

Patients eligible for TAVR require imaging to precisely measure the size of the aortic annulus in order ... requires a left lateral thoracotomy and direct puncture of the left ventricular apex.

At 5 years, there was no difference in death or disabling stroke between transcatheter aortic valve replacement and surgery in patients at low surgical risk. Both groups had improvements in ...

Medtronic has reported late-breaking data from the randomised Evolut Low Risk Trial’s five-year outcomes of the Evolut transcatheter aortic valve replacement (TAVR) system in low-risk aortic ...

Researchers found that at five years, patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke.

The BHF PROTECT-TAVI trial enrolled 7,635 patients undergoing TAVR for aortic stenosis at 33 centers in the United Kingdom between 2020-2024, representing about 30% of all UK patients who received ...